Comprehensive assessment of genetic variants within TCF4 in Fuchs’ endothelial corneal dystrophy

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 9, 2014, Pages 6101-6107

  Wieben, Eric D ^a,b   Aleff, Ross A ^a   Eckloff, Bruce W ^b   Atkinson, Elizabeth J ^b   Baheti, Saurabh ^b   Middha, Sumit ^b   Brown, William L ^b   Patel, Sanjay V ^b   Kocher, Jean Pierre A ^b   Baratz, Keith H ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Fuchs dystrophy; Repeat expansion; TCF4; Transcription factor 4; Trinucleotide

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; GENETIC MARKER; PRIMER DNA; TCF4 PROTEIN, HUMAN;

AGED; ALLELE; ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SLIT LAMP; TRANSCRIPTION FACTOR 4 GENE; TRINUCLEOTIDE REPEAT; CHEMISTRY; DNA SEQUENCE; GENETIC MARKER; GENETICS; GENOTYPE;

AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; DNA PRIMERS; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; GENETIC MARKERS; GENOTYPE; HUMANS; INTRONS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84908106639     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14958     Document Type: Article

References (33)

1. Wilson SE, Bourne WM. Fuchs’ dystrophy. Cornea. 1988;7:2–18.
2. Chi HH, Teng CC, Katzin HM. Histopathology of primary endothelial-epithelial dystrophy of the cornea. Am J Ophthalmol. 1958;45:518–535.
3. Eye Bank Association of America. 2012 Eye Banking Statistical Report. Washington, DC: EBAA; 2013.
4. Tan JC, Holland SP, Dubord PJ, Moloney G, McCarthy M, Yeung SN. Evolving indications for and trends in keratoplasty in British Columbia, Canada, from 2002 to 2011: a 10-year review. Cornea. 2014;33:252–256.
5. Keenan TD, Jones MN, Rushton S, Carley FM. Trends in the indications for corneal graft surgery in the United Kingdom: 1999 through 2009. Arch Ophthalmol. 2012;130:621–628.
6. Doors M, Berendschot TT, Touwslager W, Webers CA, Nuijts RM. Phacopower modulation and the risk for postoperative corneal decompensation: a randomized clinical trial. JAMA Ophthalmol. 2013;131:1443–1450.
7. Yamazoe K, Yamaguchi T, Hotta K, et al. Outcomes of cataract surgery in eyes with a low corneal endothelial cell density. J Cataract Refract Surg. 2011;37:2130–2136.
8. Riazuddin SA, Vasanth S, Katsanis N, Gottsch JD. Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF 4. Am J Hum Genet. 2013;93:758–764.
9. Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci. 2005;46: 1934–1939.
10. Vithana EN, Morgan P, Sundaresan P, et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nature Genet. 2006;38:755–757.
11. Riazuddin SA, Zaghloul NA, Al-Saif A, et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interactwith FCD4 on chromosome 9p. Am J Hum Genet. 2010;86:45–53.
12. Riazuddin SA, Parker DS, McGlumphy EJ, et al. Mutations in LOXHD1, a recessive-deafness locus, cause dominant lateonset Fuchs corneal dystrophy. Am J Hum Genet. 2012;90: 533–539.
13. Baratz KH, Tosakulwong N, Ryu E, et al. E2-2 protein and Fuchs’s corneal dystrophy. N Eng J Med. 2010;363:1016–1024.
14. Wieben ED, Aleff RA, Tosakulwong N, et al. A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One. 2012;7:e49083.
15. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 50 exon usage and splicing. PLoS One. 2011;6:e22138.
16. Cano A, Portillo F. An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumour progression. Cell Adh Migr. 2010;4:528–544.
17. Lechner J, Dash DP, Muszynska D, et al. Mutational spectrum of the ZEB1 gene in corneal dystrophies supports a genotypephenotype correlation. Invest Ophthalmol Vis Sci. 2013;54: 3215–3223.
18. Krafchak CM, Pawar H, Moroi SE, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet. 2005;77:694–708.
19. Krachmer JH, Bucher KD, Purcell JJ, Young CW. Inheritance of endothelial dystrophy of the cornea. Ophthalmologica. 1980; 181:301–313.
20. Breschel TS, McInnis MG, Margolis RL, et al. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21. 1. Hum Mol Genet. 1997;6:1855–1863.
21. Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am J Ophthalmol. 1967;64:1155–1158.
22. Krachmer JH, Purcell JJ Jr, Young CW, Bucher KD. Corneal endothelial dystrophy. A study of 64 families. Arch Ophthalmol. 1978;96:2036–2039.
23. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/ Map format and SAMtools. Bioinformatics. 2009;25:2078–2079.
24. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature Genet. 2011;43:491–498.
25. Truong HT, Ramos AM, Yalcin F, et al. Sequence-based genotyping for marker discovery and co-dominant scoring in germplasm and populations. PLoS One. 2012;7:e37565.
26. Eghrari AO, McGlumphy EJ, Iliff BW, et al. Prevalence and severity of Fuchs corneal dystrophy in Tangier Island. Am J Ophthalmol. 2012;153:1067–1072.
27. Igo RP Jr, Kopplin LJ, Joseph P, et al. Differing roles for TCF4 and COL8A2 in central corneal thickness and Fuchs endothelial corneal dystrophy. PLoS One. 2012;7:e46742.
28. Kuot A, Hewitt AW, Griggs K, et al. Association of TCF4 and CLU polymorphisms with Fuchs’ endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process. Eur J Hum Genet. 2012;20:632–638.
29. Li YJ, Minear MA, Rimmler J, et al. Replication of TCF4 through association and linkage studies in late-onset Fuchs endothelial corneal dystrophy. PLoS One. 2011;6:e18044.
30. Riazuddin SA, McGlumphy EJ, Yeo WS, Wang J, Katsanis N, Gottsch JD. Replication of the TCF4 intronic variant in lateonset Fuchs corneal dystrophy and evidence of independence from the FCD2 locus. Invest Ophthalmol Vis Sci. 2011;52: 2825–2829.
31. Stamler JF, Roos BR, Wagoner MD, et al. Confirmation of the association between the CF4 risk allele and Fuchs endothelial corneal dystrophy in patients from the Midwestern United States. Ophthalmic Genet. 2013;34:32–34.
32. Mootha VV, Gong X, Ku HC, Xing C. Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs’ endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2014;55:33–42.
33. Daughters RS, Tuttle DL, Gao W, et al. RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 2009;5: e1000600.